Operating Expenses Changement Date
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Arrowhead Research USD 140.1M 15.67M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Heron Therapeutics USD 56.36M 17.8M 2023-09
Incyte USD 826.07M 121.75M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Ligand Pharmaceuticals USD 31.56M 1.77M 2023-12
Merck USD 16.56B 6.35B 2023-12
Moderna USD 2.8B 1.04B 2023-12
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
TG Therapeutics USD 56.46M 5.42M 2023-12
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09
Xencor USD 79.7M 2.27M 2023-12



Arrowhead Research Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.